Janus Henderson Group PLC Enanta Pharmaceuticals Inc Transaction History

Janus Henderson Group PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$38.82 - $54.59 $328,106 - $461,394	8,452 New	8,452 $341,000
Q2 2022 Aug 15, 2022	SELL	$38.13 - $76.93 $140,547 - $283,563	-3,686 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$56.06 - $74.11 $112 - $148	2 Added 0.05%	3,686 $262,000
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $221,739 - $358,711	3,684 New	3,684 $276,000
Q1 2020 May 14, 2020	SELL	$40.22 - $62.0 $25.8 Million - $39.8 Million	-641,818 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$57.95 - $66.61 $13 Million - $14.9 Million	-223,491 Reduced 25.83%	641,818 $39.7 Million
Q3 2019 Nov 14, 2019	SELL	$60.08 - $88.17 $4.78 Million - $7.01 Million	-79,478 Reduced 8.41%	865,309 $52 Million
Q2 2019 Jul 31, 2019	BUY	$81.3 - $97.35 $5.72 Million - $6.85 Million	70,390 Added 8.05%	944,787 $79.7 Million
Q1 2019 Apr 30, 2019	BUY	$69.08 - $105.66 $8.76 Million - $13.4 Million	126,804 Added 16.96%	874,397 $83.5 Million
Q4 2018 Feb 06, 2019	BUY	$65.41 - $84.65 $40.6 Million - $52.6 Million	620,983 Added 490.47%	747,593 $53 Million
Q3 2018 Nov 09, 2018	SELL	$85.46 - $126.37 $769 - $1,137	-9 Reduced 0.01%	126,610 $10.8 Million
Q2 2018 Aug 10, 2018	SELL	$81.85 - $120.51 $30.1 Million - $44.3 Million	-367,679 Reduced 74.38%	126,619 $14.7 Million
Q1 2018 May 14, 2018	BUY	$57.91 - $92.15 $28.6 Million - $45.5 Million	494,298 New	494,298 $40 Million

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.